Literature DB >> 2108424

Antigenicity of adult Schistosoma mansoni alkaline phosphatase.

F H Pujol1, I M Cesari.   

Abstract

Antibodies to the alkaline phosphatase (AP) of Schistosoma mansoni in infected human and mice sera were evaluated by a direct solid-phase AP immunoadsorption assay (APIA) and by Western blot and immunostaining. APIA consisted of (a) solid-phase capture of immunoglobulins from infected human or mice, (b) immunoadsorption of the enzyme antigen by the antibodies, and (c) detection of the enzymatic activity. By this procedure the appearance of the anti-AP response in mice was detected around 50 days post-infection; this response was not specific for an AP of a given schistosome strain and it was not induced by an autoimmunity phenomenon. Fourteen out of 15 sera from infected people tested by APIA showed a clear antibody response against this enzyme. Immunoblots in non-reducing conditions supported APIA results indicating that the parasite AP was specifically recognized by the antibodies present in infected human and mice sera. These results suggest the possible usefulness of the schistosome AP as a marker for S. mansoni infection.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2108424     DOI: 10.1111/j.1365-3024.1990.tb00947.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  8 in total

1.  Immunoblot analysis of membrane antigens of Schistosoma mansoni, Schistosoma intercalatum, and Schistosoma haematobium against Schistosoma-infected patient sera.

Authors:  Italo M Cesari; Diana E Ballen; L Mendoza; Alain Ferrer; Jean-Pierre Pointier; Maryvonne Kombila; Dominique Richard-Lenoble; Andre Théron
Journal:  Parasitol Res       Date:  2010-03-24       Impact factor: 2.289

2.  The efficacy of human schistosomicide treatment may depend on the rate of transmission.

Authors:  Nelmar García; Gina Isturiz; Silvia Aular; Renzo Nino Incani
Journal:  Parasitol Res       Date:  2006-01-18       Impact factor: 2.289

3.  Comparative evaluation of Schistosoma mansoni, Schistosoma intercalatum, and Schistosoma haematobium alkaline phosphatase antigenicity by the alkaline phosphatase immunoassay (APIA).

Authors:  I M Cesari; D E Ballén; L Mendoza; A Ferrer; J-P Pointier; M Kombila; D Richard-Lenoble; A Théron
Journal:  Parasitol Res       Date:  2014-01-23       Impact factor: 2.289

4.  Detection of Schistosoma mansoni membrane antigens by immunoblot analysis of sera of patients from low-transmission areas.

Authors:  Italo M Cesari; Diana E Ballen; Leydi Mendoza; César Matos
Journal:  Clin Diagn Lab Immunol       Date:  2005-02

5.  Treatment of Schistosoma mansoni with miltefosine in vitro enhances serological recognition of defined worm surface antigens.

Authors:  Marwa H El-Faham; Maha M Eissa; Joseph E Igetei; Eglal I Amer; Susan Liddell; Mervat Z El-Azzouni; Michael J Doenhoff
Journal:  PLoS Negl Trop Dis       Date:  2017-08-25

Review 6.  Schistosome immunomodulators.

Authors:  Sreemoyee Acharya; Akram A Da'dara; Patrick J Skelly
Journal:  PLoS Pathog       Date:  2021-12-30       Impact factor: 7.464

7.  Immunoprotection of mice against Schistosomiasis mansoni using solubilized membrane antigens.

Authors:  Guidenn Sulbarán; Oscar Noya; Beatríz Brito; Diana E Ballén; Italo M Cesari
Journal:  PLoS Negl Trop Dis       Date:  2013-06-20

8.  Schistosoma mansoni Adult Worm Protective and Diagnostic Proteins in n-Butanol Extracts Revealed by Proteomic Analysis.

Authors:  Guidenn Sulbarán; Giovani C Verissimo da Costa; Sandra Losada; José M Peralta; Italo M Cesari
Journal:  Pathogens       Date:  2021-12-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.